Abstract:PURPOSE. Choroidal neovascularization (CNV) is a severe complication of AMD. The Wnt signaling pathway has been shown to mediate angiogenesis. The purpose of this study was to investigate the pathogenic role of the Wnt pathway in CNV and explore the therapeutic potential of a novel Wnt signaling inhibitor in CNV.METHODS. Adult rats and mice were photocoagulated using diode laser to induce CNV. On the same day, the animals were intravitreally injected with a monoclonal antibody (Mab2F1) blocking LRP6 or nonspec… Show more
“…Therefore, attenuation of the Wnt/β-catenin pathway may be a potential strategy for treating CNV. Monoclonal antibody (Mab)2F1, a novel inhibitor of the canonical Wnt pathway, has been demonstrated to suppress the hypoxia-induced activation of Wnt signaling in cultured RPE cells, thereby ameliorating CNV (27). Similar to the role of Mab2F1 in RPE cells under hypoxic conditions, in the present study, it was demonstrated that knockdown of DKK2 inhibited the hypoxia-induced expression of β-catenin in RPE cells.…”
Section: Discussionsupporting
confidence: 67%
“…A key regulator of this pathway is intracellular β-catenin, which is a transcription coactivator (26). It has been reported that the aberrant upregulation of the Wnt/β-catenin signaling pathway at multiple levels, including Wnt ligands, low-density lipoprotein receptor-related protein 6 and β-catenin, has been observed in laser-induced CNV models (27). In addition, nuclear β-catenin regulates gene transcription by interacting with Wnt target and activator genes (T-cell factor-1/lymphoid enhancer binding factor-1) and knockdown of HIF-1α inhibits the hypoxia-increased accumulation of β-catenin in the nucleus (28).…”
Abstract. Hypoxia has been demonstrated to be a proangiogenic factor that induces vascular endothelial growth factor (VEGF) in retinal pigment epithelial (RPE) cells. Dickkopf2 (DKK2), originally known as Wnt antagonist, has recently been demonstrated to have an important regulatory role in angiogenesis; however, the specific role of DKK2 in RPE cells is not known. In the present study, the effects of DKK2 on VEGF expression under hypoxic conditions were investigated, as well as the molecular mechanisms involved. The results demonstrated that the expression of DKK2 was markedly increased under hypoxic conditions compared with normoxic conditions. Knockdown of DKK2 markedly attenuated the CoCl 2 -induced expression of hypoxia-inducible factor (HIF)-1α and VEGF in RPE cells. Furthermore, knockdown of DKK2 markedly inhibited the expression of β-catenin induced by hypoxia. In conclusion, the findings of the present study demonstrate that knockdown of DKK2 inhibits the hypoxia-induced production of VEGF by suppressing the activation of the Wnt/β-catenin signaling pathway.
“…Therefore, attenuation of the Wnt/β-catenin pathway may be a potential strategy for treating CNV. Monoclonal antibody (Mab)2F1, a novel inhibitor of the canonical Wnt pathway, has been demonstrated to suppress the hypoxia-induced activation of Wnt signaling in cultured RPE cells, thereby ameliorating CNV (27). Similar to the role of Mab2F1 in RPE cells under hypoxic conditions, in the present study, it was demonstrated that knockdown of DKK2 inhibited the hypoxia-induced expression of β-catenin in RPE cells.…”
Section: Discussionsupporting
confidence: 67%
“…A key regulator of this pathway is intracellular β-catenin, which is a transcription coactivator (26). It has been reported that the aberrant upregulation of the Wnt/β-catenin signaling pathway at multiple levels, including Wnt ligands, low-density lipoprotein receptor-related protein 6 and β-catenin, has been observed in laser-induced CNV models (27). In addition, nuclear β-catenin regulates gene transcription by interacting with Wnt target and activator genes (T-cell factor-1/lymphoid enhancer binding factor-1) and knockdown of HIF-1α inhibits the hypoxia-increased accumulation of β-catenin in the nucleus (28).…”
Abstract. Hypoxia has been demonstrated to be a proangiogenic factor that induces vascular endothelial growth factor (VEGF) in retinal pigment epithelial (RPE) cells. Dickkopf2 (DKK2), originally known as Wnt antagonist, has recently been demonstrated to have an important regulatory role in angiogenesis; however, the specific role of DKK2 in RPE cells is not known. In the present study, the effects of DKK2 on VEGF expression under hypoxic conditions were investigated, as well as the molecular mechanisms involved. The results demonstrated that the expression of DKK2 was markedly increased under hypoxic conditions compared with normoxic conditions. Knockdown of DKK2 markedly attenuated the CoCl 2 -induced expression of hypoxia-inducible factor (HIF)-1α and VEGF in RPE cells. Furthermore, knockdown of DKK2 markedly inhibited the expression of β-catenin induced by hypoxia. In conclusion, the findings of the present study demonstrate that knockdown of DKK2 inhibits the hypoxia-induced production of VEGF by suppressing the activation of the Wnt/β-catenin signaling pathway.
“…All of these genes are potent proangiogenic genes associated with ocular angiogenesis. FZD4 is a receptor for Wnt signaling, which is a highly conserved angiogenic pathway activated in both OIR and laser-induced CNV models (16,33,34). On the other hand, Dll4/Notch signaling controls vessel sprouting and branching, and inhibition of DLL4 showed reduced pathological neovessels in OIR (35).…”
Pathologic ocular neovascularization commonly causes blindness. It is critical to identify the factors altered in pathologically proliferating versus normally quiescent vessels to develop effective targeted therapeutics. MicroRNAs regulate both physiological and pathological angiogenesis through modulating expression of gene targets at the posttranscriptional level. However, it is not completely understood if specific microRNAs are altered in pathologic ocular blood vessels, influencing vascular eye diseases. Here we investigated the potential role of a specific microRNA, miR-150, in regulating ocular neovascularization. We found that miR-150 was highly expressed in normal quiescent retinal blood vessels and significantly suppressed in pathologic neovessels in a mouse model of oxygen-induced proliferative retinopathy. MiR-150 substantially decreased endothelial cell function including cell proliferation, migration, and tubular formation and specifically suppressed the expression of multiple angiogenic regulators, CXCR4, DLL4, and FZD4, in endothelial cells. Intravitreal injection of miR-150 mimic significantly decreased pathologic retinal neovascularization in vivo in both wild-type and miR-150 knockout mice. Loss of miR-150 significantly promoted angiogenesis in aortic rings and choroidal explants ex vivo and laser-induced choroidal neovascularization in vivo. In conclusion, miR-150 is specifically enriched in quiescent normal vessels and functions as an endothelium-specific endogenous inhibitor of pathologic ocular neovascularization.neovascularization | endothelial cells | microRNA | miR-150 | retinopathy
“…[7][8][9][10][11] Recently, the Wnt pathway has been suggested to be a pathogenic mechanism of AMD, especially nAMD. 8 The therapeutic effects of Wnt inhibitors, such as monoclonal antibodies to Wnts, have been demonstrated in a mouse model of wet AMD. 8 However, others reported that increased Wnt signaling in light-induced retinal degeneration plays a role in retinal protection.…”
mentioning
confidence: 99%
“…8 The therapeutic effects of Wnt inhibitors, such as monoclonal antibodies to Wnts, have been demonstrated in a mouse model of wet AMD. 8 However, others reported that increased Wnt signaling in light-induced retinal degeneration plays a role in retinal protection. 7,12 They suggested that upregulated Wnt signaling in Müller glia during retinal degeneration could be a protective mechanism to prevent further photoreceptor injury.…”
Citation: Park KH, Choi AJ, Yoon J, et al. Wnt modulators in the aqueous humor are associated with outer retinal damage severity in patients with neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2014;55:5522-5530. DOI: 10.1167/iovs.14-14566 PURPOSE. To investigate the associations of the Wnt modulators Wnt inhibitory factor 1 (WIF-1) and Dickkopf 3 (DKK-3) in the aqueous humor with neovascular age-related macular degeneration (nAMD) and to determine their clinical implications.METHODS. Seventy-four nAMD patients initially treated with an intravitreal injection of ranibizumab (IVR) and 74 age-and sex-matched controls were studied. Aqueous humor WIF-1 and DKK-3 levels were measured by Western blotting and an ELISA before and 1 month after two consecutive IVRs (pre-and post-IVR). Visual acuity assessments and spectral domain optical coherence tomography were performed pre-and post-IVR.
RESULTS.Western blotting showed increased WIF-1 and DKK-3 in 12 nAMD patients compared with 12 controls. The ELISA analysis demonstrated elevated WIF-1 (pre) and DKK-3 (pre) in 62 patients compared with 62 controls (54.7 vs. 23.0 and 114.3 vs. 93.0 ng/mL, respectively). In multivariate analyses, high WIF-1 (pre) levels were associated with increased disruption in the photoreceptor junction's inner and outer segments (IS/OS) (pre and post) and high WIF-1 (post) levels. Interestingly, WIF-1 (pre) levels were significantly higher in type 3 neovascularization (NV) patients than in type 1 or 2 NV (90.5 6 36.7 vs. 48.3 6 22.5 and 41.3 6 28.8 ng/mL, respectively). However, choroidal thickness was not correlated with WIF-1 levels.CONCLUSIONS. We report, for the first time, the possibility of phenotypic, anatomic, and ocular proteomic correlations, demonstrating correlated WIF-1 and DKK-3 upregulation in nAMD patients' aqueous humor. Secreted WIF-1, reflecting the degree of retinal structure damage, may be a new biomarker for the retina's healthy and disease states.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.